Table 2 Post-LVAD outcomes.

From: Association between early ventricular arrhythmias and mortality in destination vs. bridge patients on continuous flow LVAD support

  Overall cohort (n = 341) DT group (n = 153) BTT group (n = 188) P value Early VA (n = 128) No early VA (n = 213) P value
Early post-LVAD VA n (%) 128 (37.4%) 59 (38.3%) 69 (36.6%) 0.58
New onset early post LVAD VA n (%)   25 (20.6%) 22 (15.6%) 0.29 47 (36.7%)
Late post-LVAD VA n (%) 174 (54.7%) 71 (50.0%) 103 (58.5%) 0.25 74 (64.3%) 100 (49.3%) 0.009
VA ablation n (%) 21 (6.2%) 8 (5.2%) 13 (7.0%) 0.74 16 (12.5%) 5 (2.3%)  < 0.001
30-day mortality 26 (7.6%) 16 (10.5%) 10 (5.2%) 0.07 14 (10.8%) 12 (5.6%) 0.08
90-day mortality 46 (13.4%) 30 (19.6%) 16 (8.4%) 0.002 26 (20.2%) 20 (9.3%) 0.004
Mortality beyond 90 days 97 (32.8%) 57 (46.3%) 40 (23.1%)  < 0.001 35 (34.0%) 62 (33.1%) 0.76
3-year mortality n (%) 113 (32.9%) 65 (41.9%) 48 (25.8%) 0.002 51 (39.8%) 62 (29.1%) 0.041
Heart transplant n (%) 74 (21.7%) 2 (1.3%) 72 (38.7%)  < 0.001 26 (20.3%) 48 (22.5%) 0.63
Death or heart transplant 217 (63.3%) 89 (57.4%) 128 (68.8%) 0.005 87 (68.0%) 130 (61.0%) 0.20
Death at end of follow-up 152 (44.6%) 87 (56.9%) 65 (34.6%)  < 0.001 63 (49.2%) 89 (41.8%) 0.18
  1. P values presented in bold are statistically significant (<0.05).
  2. BTT bridge to transplant, DT destination therapy, LVAD left ventricular assist device, RV right ventricle, VA ventricular arrhythmia.